Columbia, MD, United States of America

Neal Fedarko

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Johns Hopkins University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neal Fedarko. Retrieved from https://idiyas.com/inventor/neal-fedarko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Neal Fedarko: Innovator in Biomedical Research

Introduction

Neal Fedarko is a distinguished inventor based in Columbia, MD (US). He has made significant contributions to the field of biomedical research, particularly in the area of angiotensin receptor signaling and its implications for patient treatment. With a total of 2 patents, his work has the potential to impact the lives of many patients suffering from related disorders.

Latest Patents

Fedarko's latest patents include groundbreaking inventions that address critical health issues. One of his notable patents is titled "Angiotensin receptor autoantibodies as biomarker for affected usage of angiotensin receptor blockers." This invention provides methods for treating diseases associated with angiotensin receptor signaling in patients exhibiting elevated levels of ATIR autoantibodies. It also outlines methods for identifying patients who may benefit from treatment with angiotensin receptor blockers, emphasizing the importance of personalized medicine.

Another significant patent is "Complex formed by N-linked glycoproteins (SIBLINGS) and Factor H." This invention reveals that members of the small integrin-binding ligand, n-linked glycoproteins family, known as SIBLINGS, bind to complement Factor H. The methods and compositions provided can be utilized to detect SIBLINGS proteins in samples from subjects suspected of having tumors or abnormal bone turnover. Furthermore, this discovery allows for the creation of specific binding agents that facilitate the detection of SIBLINGS proteins when associated with Factor H.

Career Highlights

Throughout his career, Fedarko has worked with esteemed organizations, including the Department of Health and Human Services and Johns Hopkins University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biomedical research.

Collaborations

Some of his notable coworkers include Peter M Abadir and Alka Jain. Their collaborative efforts have further enhanced the impact of Fedarko's inventions and research.

Conclusion

Neal Fedarko's innovative work in biomedical research exemplifies the importance of scientific advancements in improving patient care. His patents not only provide valuable methods for treatment but also pave the way for future research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…